Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

Clinical trial NCT00590785 · COMPLETED

Trial details

NCT number: NCT00590785
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

High Risk Breast Cancer Positive Nodes Cyclophosphamide Doxorubicin

Start date: 1996-08-13
Primary completion: 1997-06-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.